Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients

Sponsor
Gillian Gresham (Other)
Overall Status
Recruiting
CT.gov ID
NCT04604158
Collaborator
(none)
100
1
1
19.2
5.2

Study Details

Study Description

Brief Summary

This is a single-arm, prospective, interventional study in cancer survivors and patients to examine the feasibility of a mobile health application, Elly (Elly Health Inc.), to reduce levels of anxiety, stress, loneliness, and social isolation. Participants will be given access to the Elly phone application developed by Elly Health Inc. and will be asked to complete questionnaires measuring quality of life at multiple timepoints during the study.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
IIT2020-13-GRESHAM-ELLY: Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
Actual Study Start Date :
Dec 2, 2020
Anticipated Primary Completion Date :
Jul 8, 2022
Anticipated Study Completion Date :
Jul 8, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Elly Mobile Phone Application

Behavioral: Elly Mobile Phone Application
The Elly mobile phone application delivers daily audio recording aimed at reducing anxiety, stress, loneliness, and social isolation.
Other Names:
  • Elly App
  • Outcome Measures

    Primary Outcome Measures

    1. Absolute change in patient-reported anxiety scores at Day 30 compared with baseline. [30 days]

      Absolute change in patient-reported anxiety scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 30 compared with baseline. The minimum value is 6 and maximum value is 30, and a lower score means a better outcome.

    Secondary Outcome Measures

    1. Absolute change in patient-reported anxiety scores at Day 14 compared with baseline. [14 days]

      Absolute change in patient-reported anxiety scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 14 compared with baseline. The minimum value is 6 and maximum value is 30, and a lower score means a better outcome.

    2. Absolute change in patient-reported anxiety scores at Day 60 compared with baseline. [60 days]

      Absolute change in patient-reported anxiety scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 60 compared with baseline. The minimum value is 6 and maximum value is 30, and a lower score means a better outcome.

    3. Absolute change in patient-reported anxiety scores at Day 90 compared with baseline. [90 days]

      Absolute change in patient-reported anxiety scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 90 compared with baseline. The minimum value is 6 and maximum value is 30, and a lower score means a better outcome.

    4. Absolute change in patient-reported anxiety scores at Day 120 compared with baseline. [120 days]

      Absolute change in patient-reported anxiety scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 120 compared with baseline. The minimum value is 6 and maximum value is 30, and a lower score means a better outcome.

    5. Absolute change in patient-reported anxiety scores at Day 150 compared with baseline. [150 days]

      Absolute change in patient-reported anxiety scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 150 compared with baseline. The minimum value is 6 and maximum value is 30, and a lower score means a better outcome.

    6. Absolute change in patient-reported anxiety scores at Day 180 compared with baseline. [180 days]

      Absolute change in patient-reported anxiety scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 180 compared with baseline. The minimum value is 6 and maximum value is 30, and a lower score means a better outcome.

    7. Absolute change in patient-reported depression scores at Day 30 compared with baseline. [30 days]

      Absolute change in patient-reported depression scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 30 compared with baseline. The minimum value is 8 and maximum value is 40, and a lower score means a better outcome.

    8. Absolute change in patient-reported depression scores at Day 60 compared with baseline. [60 days]

      Absolute change in patient-reported depression scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 60 compared with baseline. The minimum value is 8 and maximum value is 40, and a lower score means a better outcome.

    9. Absolute change in patient-reported depression scores at Day 90 compared with baseline. [90 days]

      Absolute change in patient-reported depression scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 90 compared with baseline. The minimum value is 8 and maximum value is 40, and a lower score means a better outcome.

    10. Absolute change in patient-reported depression scores at Day 120 compared with baseline. [120 days]

      Absolute change in patient-reported depression scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 120 compared with baseline. The minimum value is 8 and maximum value is 40, and a lower score means a better outcome.

    11. Absolute change in patient-reported depression scores at Day 150 compared with baseline. [150 days]

      Absolute change in patient-reported depression scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 150 compared with baseline. The minimum value is 8 and maximum value is 40, and a lower score means a better outcome.

    12. Absolute change in patient-reported depression scores at Day 180 compared with baseline. [180 days]

      Absolute change in patient-reported depression scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 180 compared with baseline. The minimum value is 8 and maximum value is 40, and a lower score means a better outcome.

    13. Absolute change in patient-reported loneliness scores at Day 30 compared with baseline. [30 days]

      Absolute change in patient-reported loneliness scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 30 compared with baseline. The minimum value is 5 and maximum value is 25, and a lower score means a better outcome.

    14. Absolute change in patient-reported loneliness scores at Day 60 compared with baseline. [60 days]

      Absolute change in patient-reported loneliness scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 60 compared with baseline. The minimum value is 5 and maximum value is 25, and a lower score means a better outcome.

    15. Absolute change in patient-reported loneliness scores at Day 90 compared with baseline. [90 days]

      Absolute change in patient-reported loneliness scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 90 compared with baseline. The minimum value is 5 and maximum value is 25, and a lower score means a better outcome.

    16. Absolute change in patient-reported loneliness scores at Day 120 compared with baseline. [120 days]

      Absolute change in patient-reported loneliness scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 120 compared with baseline. The minimum value is 5 and maximum value is 25, and a lower score means a better outcome.

    17. Absolute change in patient-reported loneliness scores at Day 150 compared with baseline. [150 days]

      Absolute change in patient-reported loneliness scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 150 compared with baseline. The minimum value is 5 and maximum value is 25, and a lower score means a better outcome.

    18. Absolute change in patient-reported loneliness scores at Day 180 compared with baseline. [180 days]

      Absolute change in patient-reported loneliness scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 180 compared with baseline. The minimum value is 5 and maximum value is 25, and a lower score means a better outcome.

    19. Absolute change in patient-reported social isolation scores at Day 30 compared with baseline. [30 days]

      Absolute change in patient-reported social isolation scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 30 compared with baseline. The minimum value is 4 and maximum value is 20, and a lower score means a better outcome.

    20. Absolute change in patient-reported social isolation scores at Day 60 compared with baseline. [60 days]

      Absolute change in patient-reported social isolation scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 60 compared with baseline. The minimum value is 4 and maximum value is 20, and a lower score means a better outcome.

    21. Absolute change in patient-reported social isolation scores at Day 90 compared with baseline. [90 days]

      Absolute change in patient-reported social isolation scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 90 compared with baseline. The minimum value is 4 and maximum value is 20, and a lower score means a better outcome.

    22. Absolute change in patient-reported social isolation scores at Day 120 compared with baseline. [120 days]

      Absolute change in patient-reported social isolation scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 120 compared with baseline. The minimum value is 4 and maximum value is 20, and a lower score means a better outcome.

    23. Absolute change in patient-reported social isolation scores at Day 150 compared with baseline. [150 days]

      Absolute change in patient-reported social isolation scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 150 compared with baseline. The minimum value is 4 and maximum value is 20, and a lower score means a better outcome.

    24. Absolute change in patient-reported social isolation scores at Day 180 compared with baseline. [180 days]

      Absolute change in patient-reported social isolation scores as measures using the NIH (National Institutes of Health) PROMIS (Patient-Reported Outcomes Measurement Information System) questionnaire at Day 180 compared with baseline. The minimum value is 4 and maximum value is 20, and a lower score means a better outcome.

    25. Frequency of Elly app use [180 days]

      Frequency of study participant opening the Elly app

    26. Elly app login amount [180 days]

      Number of logins to Elly app by study participant

    27. Duration of Elly app use [180 days]

      Duration of each Elly app session by study participant

    28. Participant's experience with Elly app at Day 14-30. [Day 30]

      Participant's experience with Elly app based on qualitative interview done between Day 14-30.

    29. Participant's experience with Elly app at Day 180-360. [Day 360]

      Participant's experience with Elly app based on qualitative interview done between Day 180-360.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Diagnosis of cancer of any type and currently receiving cancer-targeted treatment or have received cancer-targeted treatment within 6 months of consent date based on self-report. Cancer-targeted treatment includes chemotherapy, radiation therapy, hormonal therapy, biologic therapy, immunotherapy, and surgery.

    • 18 years or older

    • Access to and ability to use an iPhone (SE+, iOS 12.4+)

    • Ability to understand and read English

    • Have an understanding, ability, and willingness to fully comply with study procedures and restrictions

    Exclusion Criteria:
    • Hearing loss or vision impairment that would preclude the participant from accessing and using the app (use of hearing aids or visual aids is acceptable) based on self-report.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Cedars Sinai Medical Center Los Angeles California United States 90048

    Sponsors and Collaborators

    • Gillian Gresham

    Investigators

    • Principal Investigator: Gillian Gresham, PhD, Cedars-Sinai Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Gillian Gresham, Principal Investigator, Cedars-Sinai Medical Center
    ClinicalTrials.gov Identifier:
    NCT04604158
    Other Study ID Numbers:
    • IIT2020-13-GRESHAM-ELLY
    First Posted:
    Oct 27, 2020
    Last Update Posted:
    Dec 9, 2021
    Last Verified:
    Dec 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Gillian Gresham, Principal Investigator, Cedars-Sinai Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 9, 2021